Abstract
Relevance: Breast cancer (BC) is the leading cause of worldwide female cancer mortality. The constant development of treatment
 strategies and diagnostic tools has increased the survival rate for BC. Next-generation genome sequencing (NGS) identifies the genetic
 changes responsible for tumor emergence, development, and metastasis. NGS has expanded the capacities of BC diagnostics, treatment,
 and early prevention in women.
 The study aimed to identify breast cancer risk factors in women.
 Methods: Publications were obtained from the following databases: PubMed, Google Scholar, and eLibrary. The depth of the search
 was 5 to 10 years. As a result, 100 literary sources were identified, of which 26 publications formed the scientific material for this review.
 Results: Breast cancer is a heterogeneous disease driven by genetic abnormalities and epigenetic alterations.
 Conclusion: Gene mutations do not change. Genetic testing shall be introduced as a preventive measure to reduce BC incidence.
 Lifestyle-related BC risk factors can be addressed to minimize BC risk.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
